Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [518]
News [1463]
Articles [67]
Editorials [2]
Conferences [72]
elearning [5]
Lymphatic vessels that help cancers spread can also boost immune therapies
Lymphatic vessels that help cancers spread can also boost immune therapies
Double agents: Vessels that help cancers spread can also boost immunotherapy
Double agents: Vessels that help cancers spread can also boost immunotherapy
ESMO 2017: Combination targeted adjuvant therapy doubles relapse-free survival in stage III melanoma
ESMO 2017: Combination targeted adjuvant therapy doubles relapse-free survival in stage III melanoma
ESMO 2017: Adjuvant nivolumab superior to ipilimumab in surgically resected stage III/IV melanoma
ESMO 2017: Adjuvant nivolumab superior to ipilimumab in surgically resected stage III/IV melanoma
Researchers discover why redheads are more prone to melanoma
Researchers discover why redheads are more prone to melanoma
Immunotherapy combination safe and 62 percent effective in metastatic melanoma patients
Immunotherapy combination safe and 62 percent effective in metastatic melanoma patients
The STING of death in T cells
The STING of death in T cells
FDG-PET/CT predicts melanoma patients' response to immune checkpoint inhibitor therapy
FDG-PET/CT predicts melanoma patients' response to immune checkpoint inhibitor therapy
Most melanomas don't arise from existing moles
Most melanomas don't arise from existing moles
Upon prolonged irradiation, human stem cells' defenses are activated
Upon prolonged irradiation, human stem cells' defenses are activated

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation